Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm.
Journal: Blood
Published: June 07, 2024
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 07, 2024
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
Journal: The New England journal of medicine
Published: August 30, 2023
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: April 14, 2022
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012.
Journal: Transplantation and cellular therapy
Published: February 01, 2022
Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent Patients.
Journal: Transplantation and cellular therapy
Published: June 08, 2021
Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant.
Journal: Blood advances
Published: January 04, 2021
Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma.
Journal: Leukemia
Published: October 27, 2020
Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 04, 2020
Last Updated: 09/26/2026